Biomedical foundation supports technology aimed at destroying cancer cells
A new technology, using electric pulses to destroy cancer tissue and named by NASA Tech Briefs as one of seven key technological breakthroughs of 2007, is receiving additional support aimed at moving the procedure to the marketplace.
One of its lead developers, Rafael V. Davalos, a faculty member of the Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences (SBES), received a $240,000 grant from the Wallace H. Coulter Foundation and $25,000 from the Wake Forest Comprehensive Cancer Center.
Davalos' grant from Coulter is an Early Career Translational Research Award in Biomedical Engineering. This early career awards program provides funding for assistant professors in established biomedical engineering departments within North America. The award seeks to support biomedical research that Coulter considers promising -- with the goal of progressing toward commercial development.
The technology, irreversible electroporation (IRE), was invented by Davalos and Boris Rubinsky, a bioengineering professor at the University of California, Berkeley.
Electroporation is a phenomenon that increases the permeability of a cell from none to a reversible opening to an irreversible opening. With the latter, the cell will die. For decades, biologists have used reversible electroporation in laboratories to introduce drugs and genes into cells while trying to avoid irreversible electroporation. By contrast, biomedical engineers Davalos and Rubinsky are now using irreversible electroporation to target cancer cells in the body.
Irreversible electroporation would be a minimally invasive surgical focal-ablation technique that could remove the undesirable tissue without the use of heat such as radiation. The irreversible electroporation procedure involves placing small needles near the targeted region. The needles deliver a series of low energy microsecond electric pulses to the targeted tissue and the area treated can be monitored in real time using ultrasound. In laboratory testing, irreversible electroporation destroyed targeted tissue with sub-millimeter resolution, and it proved easy to control and to be precise.
Furthermore, "the procedure spares nerves and major blood vessels, enabling treatment in otherwise inoperable areas," Davalos, the 2006 recipient of the Hispanic Engineer National Achievement Award for Most Promising Engineer, added.
Davalos and his colleagues published the first experiments on using irreversible electroporation on tumors in the November 2007 issue of PLoS ONE. Their optimal parameters achieved complete regression in 92 percent of the treated tumors in vivo in preclinical mouse models. These results were achieved with a single treatment that lasted less than five minutes. Collaborator Lluis M. Mir, director of the Laboratory of Vectorology and Gene Transfer research of the Institut Gustave Rousssy, the leading cancer research center in Europe, and one of the Centre National de la Recherche Scientifique (CNRS), led the study.
In April 2008, Gary Onik (http://www.hopeforprostatecancer.com/gon-onik.asp), a radiologist with Florida Hospital and Rubinsky conducted a pilot study (http://www.hopeforprostatecancer.com/) on five people on soft tissue in the prostate to prove the safety of the procedure on humans.
Davalos' collaborators on the Coulter Foundation grant are: Mir; John Robertson, professor of biomedical science; and John Rossmeisl, an assistant professor of small animal clinical services, both of whom are in the Virginia-Maryland Regional College of Veterinary Medicine and Waldemar Debinski of Wake Forest.
Davalos' Virginia Tech collaborators on the grant from Wake Forest are Robertson and Nichole Rylander, assistant professor of mechanical engineering and also a member of the Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences. Wake Forest researcher Suzy Torti, of its cancer biology department, is also working with the group.
Lynn A. Nystrom | VT News
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.
Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...
Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.
They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...
Oceans formed before Tharsis and evolved together, shaping climate history of Mars
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
Researchers from Göttingen University discover additional function of opsins
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...